Table 2.
Association between circulating NT-proBNP, testosterone and sex hormone-binding globulin
Men | Women | |||
---|---|---|---|---|
Association with log NT-proBNP | Beta* (SE) | P value | Beta* (SE) | P value |
Entire sample Single variable |
||||
Log free testosterone | −0.30 (0.11) | 0.007 | −0.54 (0.05) | <0.0001 |
Log sex hormone-binding globulin | 0.23 (0.03) | <0.0001 | 0.23 (0.02) | <0.0001 |
| ||||
Entire sample Multivariable† |
||||
Log free testosterone | −0.03 (0.11) | 0.78 | −0.47 (0.06) | <0.0001 |
Log sex hormone-binding globulin | 0.12 (0.03) | <0.0001 | 0.25 (0.02) | <0.0001 |
| ||||
Non-diabetics only Multivariable‡ |
||||
Log free testosterone | −0.05 (0.12) | 0.65 | −0.45 (0.06) | <0.0001 |
Log sex hormone-binding globulin | 0.13 (0.03) | 0.0001 | 0.24 (0.02) | <0.0001 |
Beta coefficients represent the mean change in log NT-proBNP per 1 SD difference in log free testosterone or log sex hormone-binding globulin; For single variable analyses, N=1880 in men (both models); 2144 in women (model containing log free testosterone); and 2147 in women (model containing log sex hormone-binding globulin).
Adjusted for age, body mass index, systolic blood pressure, diastolic blood pressure, serum creatinine, antihypertensive medications, diabetes mellitus, and smoking; N=1871 in men (both models); 2123 in women (model containing log free testosterone); and 2126 in women (model containing log sex hormone-binding globulin).
Adjusted for age, body mass index, systolic blood pressure, diastolic blood pressure, serum creatinine, antihypertensive medications, smoking and homeostatic model assessment of insulin resistance; N=1650 in men (both models); 1857 in women (model containing log free testosterone); and 1859 in women (model containing log sex hormone-binding globulin).